Close Menu

NEW YORK – Oxford Nanopore Technologies said on Tuesday that it is preparing for an initial public offering later this year on the London Stock Exchange.

According to IP Group, which holds a 15 percent stake in UK-based Oxford Nanopore, the firm currently expects to go public on the London Stock Exchange in the second half of 2021, but the timing will depend on market conditions and "other matters not fully within its control."

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A small, early-stage trial of a combination therapy for brain cancer reports favorable responses in two patients, according to the Guardian.

Nature News writes that viral genomic surveillance in the US faces systemic issues.

President Joe Biden is seeking an increase in federal spending, including higher budgets for the National Institutes of Health and Centers for Disease Control and Prevention.

In PLOS this week: sex-stratified genome-wide association study of chronic pain, sequencing data from Indigenous Mexican groups, and more.